SARS-COV-2 Vaccines and Neurodegenerative Disease
Since December 2021, when several novel unprecedented vaccines against SARS-CoV-2 began to be approved for emergency use, there ...
Stay updated with breaking news from Current Clinical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Since December 2021, when several novel unprecedented vaccines against SARS-CoV-2 began to be approved for emergency use, there ...
Hyperbaric therapy can be an effective adjunctive approach for inflammatory bowel disease- read the full article online
Share this article Share this article ResearchAndMarkets.com's offering. Pancreatic cancer is currently the fourth leading cause of cancer-related deaths in the United States, following lung cancer and breast cancer and seventh leading cause of cancer related deaths worldwide with 432,242 related deaths being reported in 2018. Pancreatic adenocarcinoma (PDAC), classified as an exocrine pancreatic cancer, is considered to be the most common type of pancreatic cancer, accounting for 80% of all pancreatic cancer diagnoses. The treatment paradigm for pancreatic cancer is predominantly composed o...